Main competitors
Dividend Yield (N) Dividend Yield (N+1) P/E (N) Price to Book (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Capi.($)
0.28%0.38%34.51x3.29x8.72x26.28x30.15x 5.5B
0.51%0.58%19.62x2.33x4.52x12.82x13.91x 79.5B
0.57%0.59%27.86x3.88x5.53x15.96x20.2x 55.91B
-.--%0.03%45.16x6.73x13.63x25.29x29.48x 51.92B
2.83%3.17%36.44x2.54x3.68x10.6x12.04x 49.05B
-.--%-.--%16.09x1.37x2.96x8.62x9.54x 27.95B
-.--%-.--%-8.06x3.29x8.82x-6.56x-6.38x 22.1B
-.--%-.--%14.88x2.56x2.38x7.53x7.08x 18.84B
-.--%0.23%74.55x7.39x8.82x88.19x81.77x 18.69B
-.--%-.--%649.24x3.35x5.07x12.96x45.09x 14.46B
-.--%-.--%-36.06x-5.88x16.63x-46.35x-55.17x 13.84B
-.--%-.--%14.03x - 3.32x12.89x26.38x 11.6B
-.--%-.--%-185.43x94.56x8.05x202.05x-176.56x 8.16B
-.--%-.--%32.29x - - - - 7.45B
-.--%-.--%-220.63x - - - - 7.34B
3.8%2.77%4.9x1.91x2.07x3.08x3.13x 6.99B
2.77%2.6%12.47x1.06x1.84x7.37x9.7x 6.72B
1.28%1.44%20.9x1.23x - - - 6.03B
Average 0.67% 0.66% 30.71x 8.64x 6.40x 25.38x 3.36x 22.89B
Weighted average by Cap. 0.64% 0.7% 38.32x 5.08x 6.46x 18.38x 13.17x
Biopharmaceuticals
SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW